Rallybio Corp: Director Changes and Executive Compensation Update
Ticker: RLYB · Form: 8-K · Filed: Jun 27, 2025 · CIK: 1739410
| Field | Detail |
|---|---|
| Company | Rallybio Corp (RLYB) |
| Form Type | 8-K |
| Filed Date | Jun 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, executive-compensation, board-changes
Related Tickers: RLYB
TL;DR
Rallybio swapped a director and updated exec pay. Board changes are in.
AI Summary
Rallybio Corporation announced on June 25, 2025, the departure of Director David M. Gryska and the election of new Director Sarah E. P. Johnson. The company also reported on compensatory arrangements for its named executive officers. This filing is a current report under Section 13 or 15(d) of the Securities Exchange Act of 1934.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing primarily concerns routine corporate governance matters like director changes and executive compensation, which typically carry low immediate risk.
Key Players & Entities
- Rallybio Corporation (company) — Registrant
- David M. Gryska (person) — Departing Director
- Sarah E. P. Johnson (person) — Newly Elected Director
- June 25, 2025 (date) — Date of earliest event reported
FAQ
Who has departed from the Board of Directors at Rallybio Corporation?
David M. Gryska has departed from the Board of Directors at Rallybio Corporation as of June 25, 2025.
Who has been elected as a new Director to the Board of Rallybio Corporation?
Sarah E. P. Johnson has been elected as a new Director to the Board of Rallybio Corporation.
What is the primary purpose of this Form 8-K filing for Rallybio Corporation?
This Form 8-K filing serves as a current report detailing the departure of a director, the election of a new director, and information regarding compensatory arrangements of certain officers.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is June 25, 2025.
Under which section of the Securities Exchange Act of 1934 is Rallybio Corporation filing this report?
Rallybio Corporation is filing this report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 27, 2025 by David M. Gryska regarding Rallybio Corp (RLYB).